FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386365691> ?p ?o ?g. }

• W4386365691 endingPage "108610" @default.
• W4386365691 startingPage "108610" @default.
• W4386365691 abstract "To evaluate the effect of dapagliflozin on liver fat content (LFC) and pancreatic fat content (PFC). 84 patients with type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD) were randomly assigned to receive either dapagliflozin (n = 42) or serve as controls (n = 42). The primary endpoint is changes in LFC and PFC using magnetic resonance imaging estimated proton density fat fraction. Secondary outcomes include liver fibrosis index, inflammatory cytokine levels, and liver enzyme levels. At week 24, the dapagliflozin group significantly reduced LFC (P < 0.001) and PFC (P = 0.033) compared to the control group. Differences were also observed in serum levels of tumor necrosis factor-α (TNF-α) (P = 0.004), interleukin-6 (IL-6) (P = 0.001), and alanine aminotransferase (ALT) (P < 0.001) between the two groups. Dapagliflozin can significantly decrease LFC and PFC in patients with T2D and NAFLD. It also improves serum ALT, TNF-α, and IL-6 levels, making it a promising treatment option for NAFLD. The trial is registered on Chinese Clinical Trial Registry (Registration No. ChiCTR2100054612)." @default.
• W4386365691 created "2023-09-02" @default.
• W4386365691 creator A5002262984 @default.
• W4386365691 creator A5007849150 @default.
• W4386365691 creator A5018721355 @default.
• W4386365691 creator A5023095141 @default.
• W4386365691 creator A5032764121 @default.
• W4386365691 creator A5038909920 @default.
• W4386365691 creator A5046597133 @default.
• W4386365691 creator A5061797598 @default.
• W4386365691 creator A5063545097 @default.
• W4386365691 creator A5068379691 @default.
• W4386365691 creator A5075424614 @default.
• W4386365691 creator A5077346287 @default.
• W4386365691 creator A5079183062 @default.
• W4386365691 date "2023-10-01" @default.
• W4386365691 modified "2023-10-11" @default.
• W4386365691 title "Effect of dapagliflozin on liver and pancreatic fat in patients with type 2 diabetes and non-alcoholic fatty liver disease" @default.
• W4386365691 cites W1523363225 @default.
• W4386365691 cites W1963682935 @default.
• W4386365691 cites W1974990354 @default.
• W4386365691 cites W2047257800 @default.
• W4386365691 cites W2063437798 @default.
• W4386365691 cites W2064387090 @default.
• W4386365691 cites W2067504868 @default.
• W4386365691 cites W2091106363 @default.
• W4386365691 cites W2091330563 @default.
• W4386365691 cites W2093182588 @default.
• W4386365691 cites W2141246254 @default.
• W4386365691 cites W2195637511 @default.
• W4386365691 cites W2271384303 @default.
• W4386365691 cites W2293932895 @default.
• W4386365691 cites W2595016203 @default.
• W4386365691 cites W2619337392 @default.
• W4386365691 cites W2790286202 @default.
• W4386365691 cites W2791708447 @default.
• W4386365691 cites W2808615577 @default.
• W4386365691 cites W2810423511 @default.
• W4386365691 cites W2810729752 @default.
• W4386365691 cites W2887280312 @default.
• W4386365691 cites W2900924712 @default.
• W4386365691 cites W2909812323 @default.
• W4386365691 cites W2916103033 @default.
• W4386365691 cites W2921017081 @default.
• W4386365691 cites W2957331709 @default.
• W4386365691 cites W2973671909 @default.
• W4386365691 cites W3006028518 @default.
• W4386365691 cites W3008139277 @default.
• W4386365691 cites W3012883032 @default.
• W4386365691 cites W3020512321 @default.
• W4386365691 cites W3049394606 @default.
• W4386365691 cites W3080857839 @default.
• W4386365691 cites W3143409077 @default.
• W4386365691 cites W3154897461 @default.
• W4386365691 cites W3167353726 @default.
• W4386365691 cites W3203921331 @default.
• W4386365691 cites W4221033736 @default.
• W4386365691 cites W4225013370 @default.
• W4386365691 cites W4246340431 @default.
• W4386365691 doi "https://doi.org/10.1016/j.jdiacomp.2023.108610" @default.
• W4386365691 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37722211" @default.
• W4386365691 hasPublicationYear "2023" @default.
• W4386365691 type Work @default.
• W4386365691 citedByCount "0" @default.
• W4386365691 crossrefType "journal-article" @default.
• W4386365691 hasAuthorship W4386365691A5002262984 @default.
• W4386365691 hasAuthorship W4386365691A5007849150 @default.
• W4386365691 hasAuthorship W4386365691A5018721355 @default.
• W4386365691 hasAuthorship W4386365691A5023095141 @default.
• W4386365691 hasAuthorship W4386365691A5032764121 @default.
• W4386365691 hasAuthorship W4386365691A5038909920 @default.
• W4386365691 hasAuthorship W4386365691A5046597133 @default.
• W4386365691 hasAuthorship W4386365691A5061797598 @default.
• W4386365691 hasAuthorship W4386365691A5063545097 @default.
• W4386365691 hasAuthorship W4386365691A5068379691 @default.
• W4386365691 hasAuthorship W4386365691A5075424614 @default.
• W4386365691 hasAuthorship W4386365691A5077346287 @default.
• W4386365691 hasAuthorship W4386365691A5079183062 @default.
• W4386365691 hasBestOaLocation W43863656911 @default.
• W4386365691 hasConcept C126322002 @default.
• W4386365691 hasConcept C134018914 @default.
• W4386365691 hasConcept C142724271 @default.
• W4386365691 hasConcept C203092338 @default.
• W4386365691 hasConcept C204787440 @default.
• W4386365691 hasConcept C27081682 @default.
• W4386365691 hasConcept C2777180221 @default.
• W4386365691 hasConcept C2777422806 @default.
• W4386365691 hasConcept C2778772119 @default.
• W4386365691 hasConcept C2779134260 @default.
• W4386365691 hasConcept C535046627 @default.
• W4386365691 hasConcept C555293320 @default.
• W4386365691 hasConcept C71924100 @default.
• W4386365691 hasConcept C90924648 @default.
• W4386365691 hasConceptScore W4386365691C126322002 @default.
• W4386365691 hasConceptScore W4386365691C134018914 @default.
• W4386365691 hasConceptScore W4386365691C142724271 @default.
• W4386365691 hasConceptScore W4386365691C203092338 @default.
• W4386365691 hasConceptScore W4386365691C204787440 @default.

• next